Alle Bell- en Gongceremonies

Gongslag markeert partnerschap Bruna en Woutertje Pieterse Prijs

Met een slag op de gong markeert algemeen directeur van Bruna Fred Zeegers het partnerschap tussen Bruna en de Woutertje Pieterse Prijs. PostNL en ING, genoteerd aan de Amsterdamse beurs, zijn aandeelhouder van Postkantoren BV, waarvan Bruna een volle dochter is.

Dankzij de nieuwe samenwerking en de ondersteuning van Bruna kan de prijs voortbestaan. De bekendmaking van de 28ste winnaar van de prestigieuze prijs voor kinder- en jeugdliteratuur kan daardoor op 11 april aanstaande gewoon plaatsvinden. Vooruitlopend daarop heeft de Stichting Woutertje Pieterse Prijs voor het eerst in de geschiedenis genomineerden bekendgemaakt.

Meer informatie vindt u op: www.woutertjepieterseprijs.nl 

Download foto

Welcome to Focus Home Interactive on Alternext Paris

Jean-Pierre Bourdon, President of the board of Directors, Focus Home Interactive rings the opening bell.

Focus Home Interactive specializes in the publishing and distribution of video games for PCs and consoles.
The company has a catalogue of original titles (Blood Bowl, Sherlock Holmes, TrackMania, Runaway, Cycling Manager, Virtual Skipper, etc.).

Welcome to Focus Home Interactive on Alternext Paris

Jean-Pierre Bourdon, President of the board of Directors, Focus Home Interactive rings the opening bell.

Focus Home Interactive specializes in the publishing and distribution of video games for PCs and consoles.
The company has a catalogue of original titles (Blood Bowl, Sherlock Holmes, TrackMania, Runaway, Cycling Manager, Virtual Skipper, etc.).

Tronics Microsystems celebrates IPO on Alternext Paris

In the context of the initial public offering of Tronics, a designer and manufacturer of innovative nano and microsystems, Mr Pascal Langlois, Chief Executive Officer, Mr Stephane Renard, Founder and Chief Technology Officer and Mrs Laurence Fayand, Chief Financial Officer, open the European trading day in Paris.

Tronics designs, manufactures and sells custom or standard products in the sector of nano & microsystems with high added value.

Founded in 1997, Tronics is a recognized technological leader in the sector of nano & microsystems with high added value.
Positioned at the heart of product innovation, Tronics has technology platforms protected by a portfolio of 25 families of patents, resulting from 15 years of R&D and more than €15 million of cumulative industrial investments.
Addressing high-growth markets relying on increasing miniaturization of electronic devices, Tronics designs, manufactures and sells custom or standard products to the industry, aeronautics & security, medical and consumer markets.
Located in Crolles, near Grenoble (France) and in Dallas, Texas (United States), Tronics posted revenue of €11.6 million in 2014. It now has 88 employees, of whom 55 are engineers and scientists.

Tronics Microsystems celebrates IPO on Alternext Paris

In the context of the initial public offering of Tronics, a designer and manufacturer of innovative nano and microsystems, Mr Pascal Langlois, Chief Executive Officer, Mr Stephane Renard, Founder and Chief Technology Officer and Mrs Laurence Fayand, Chief Financial Officer, open the European trading day in Paris.

Tronics designs, manufactures and sells custom or standard products in the sector of nano & microsystems with high added value.

Founded in 1997, Tronics is a recognized technological leader in the sector of nano & microsystems with high added value.
Positioned at the heart of product innovation, Tronics has technology platforms protected by a portfolio of 25 families of patents, resulting from 15 years of R&D and more than €15 million of cumulative industrial investments.
Addressing high-growth markets relying on increasing miniaturization of electronic devices, Tronics designs, manufactures and sells custom or standard products to the industry, aeronautics & security, medical and consumer markets.
Located in Crolles, near Grenoble (France) and in Dallas, Texas (United States), Tronics posted revenue of €11.6 million in 2014. It now has 88 employees, of whom 55 are engineers and scientists.

Elis celebrates IPO on Euronext Paris

Xavier Martiré, CEO, Elis rings the European trading day in Paris.

Elis is a full-services group leader in Europe and Brazil in the rental and maintenance of professional clothing and linen, offering additional services such as water fountains, rugs and sanitation.
With more than 18,500 employees in 10 European countries and Brazil, ELIS realized in 2013 a turnover of more than 1.225 billion euros. With over a century of expertise in its traditional markets of hotel, catering and health, ELIS now delivers over 240 000 companies of all sizes and in all sectors through its network of more than 256 service centers and production, which guarantees unparalleled customer proximity.

Elis celebrates IPO on Euronext Paris

Xavier Martiré, CEO, Elis rings the European trading day in Paris.

Elis is a full-services group leader in Europe and Brazil in the rental and maintenance of professional clothing and linen, offering additional services such as water fountains, rugs and sanitation.
With more than 18,500 employees in 10 European countries and Brazil, ELIS realized in 2013 a turnover of more than 1.225 billion euros. With over a century of expertise in its traditional markets of hotel, catering and health, ELIS now delivers over 240 000 companies of all sizes and in all sectors through its network of more than 256 service centers and production, which guarantees unparalleled customer proximity.

EnterNext welcomes Safe Orthopaedics on Euronext in Paris

Yves Vignancour, CEO of Safe Orthopaedics, rings the opening bell.

Safe Orthopaedics specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable).

EnterNext welcomes Safe Orthopaedics on Euronext in Paris

Yves Vignancour, CEO of Safe Orthopaedics, rings the opening bell.

Safe Orthopaedics specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable).

Beursintroductie Bone Therapeutics op Brussel en Parijs

Vanaf 6 februari 2015 noteert Bone Therapeutics op EnterNext Brussel en Parijs. Om dit te vieren luidde CEO Enrico Bastianelli de openingsbel. Wim Goemaere, CFO, had de eer om de openingskoers op het koersenbord te noteren.  Jean-Claude Marcourt, Viceminister-president  en Waals Minister van Economie, Industrie en Innovatie was de eregast.

De vraag naar de aandelen lag 2.5 keer hoger dan het aanbod. Het biotechbedrijf haalde € 32,2 miljoen op aan € 16 per aandeel. De marktkapitalisatie bedraagt € 104.8 miljoen. 

Bone Therapeutics zal het geld gebruiken om zijn onderzoek te financieren naar celtherapiebehandelingen voor botziektes en botbreuken, aldus CEO Bastianelli in een persbericht.

Bone therapeutics is gespecialiseerd in de ontwikkeling van celtherapieproducten bestemd voor de behandeling van osteo-articulaire ziektes en regeneratie van botweefsel op basis van een technologisch platform waarmee osteoblasten uit volwassen stamcellen geproduceerd kunnen worden. Het beoogde therapeutische domein betreft toepassingen voor botreconstructie en de behandeling van ziektes als osteoporose.

Het aandeel noteert met het tradingsymbool : BOTHE.

Om meer te weten, klik op : www.bonetherapeutics.com

EnterNext is de meest actieve Europese markt in de Life Sciences sector met een marktaandeel van bijna 30% in termen van opgehaald kapitaal bij IPO’s. Debiotech aandelengenoteerd op EnterNext vertegenwoordigenmeer dan € 6,2 miljard euro in beurswaarde voor31 emittenten. Op EnterNext Brussel, vertegenwoordigen momenteel 9biotech bedrijven  € 2.2miljard aan marktkapitalisatie. In de afgelopen jaren heeft onze Next Biotech Index beter gepresteerd dan de meeste van de belangrijkste Europese indices.

EnterNext welcomes Poxel on Euronext in Paris

Thomas Kuhn, CEO of Poxel, rings the opening bell.

Poxel is a biopharmaceutical company that specializes in the development of medicines for the treatment of metabolic diseases, primarily type II diabetes.

At the end of 2014, the group had 6 products including 1 in phase II of clinical development (Imeglimin), 1 in phase of preclinical development (PXL770) and 4 in research phase.

EnterNext welcomes Poxel on Euronext in Paris

Thomas Kuhn, CEO of Poxel, rings the opening bell.

Poxel is a biopharmaceutical company that specializes in the development of medicines for the treatment of metabolic diseases, primarily type II diabetes.

At the end of 2014, the group had 6 products including 1 in phase II of clinical development (Imeglimin), 1 in phase of preclinical development (PXL770) and 4 in research phase.

Methorios Capital celebrates listing on Alternext

Fabio Palumbo, Chairman of METHORIOS opens the European trading day in Paris to celebrate their listing on Alternext.

Methorios Capital specializes in providing advisory in corporate finance transactions and assistance to small and medium companies in the research of financial solutions and corporate structures. The group's activity is organized into two sectors:
corporate finance advisory: advisory in mergers and acquisitions, in industrial and financial reorganizations, in renegotiations of lines of credit, in debt restructuring, provision of valuations of companies, implementation of strategic analyses, etc.;
investment banking: equity investment and capital markets.

Methorios Capital celebrates listing on Alternext

Fabio Palumbo, Chairman of METHORIOS opens the European trading day in Paris to celebrate their listing on Alternext.

Methorios Capital specializes in providing advisory in corporate finance transactions and assistance to small and medium companies in the research of financial solutions and corporate structures. The group's activity is organized into two sectors:
corporate finance advisory: advisory in mergers and acquisitions, in industrial and financial reorganizations, in renegotiations of lines of credit, in debt restructuring, provision of valuations of companies, implementation of strategic analyses, etc.;
investment banking: equity investment and capital markets.

EnterNext welcomes Oceasoft on Alternext in Paris

Laurent Rousseau, CEO of Oceasoft, rings the opening bell.

Oceasoft specializes in the design, manufacture and marketing of surveillance systems for physical parameters (temperature, humidity, CO2 rate or differential pressure) for the healthcare and agro-food industries. The data captured by these connected sensors ensure real-time control and tracking of products sensitive to environmental parameters, such as vaccines, drugs or foodstuffs, during their manufacture as well as during storage and transport.
55.2% of the company's turnover is made in France.

EnterNext welcomes Oceasoft on Alternext in Paris

Laurent Rousseau, CEO of Oceasoft, rings the opening bell.

Oceasoft specializes in the design, manufacture and marketing of surveillance systems for physical parameters (temperature, humidity, CO2 rate or differential pressure) for the healthcare and agro-food industries. The data captured by these connected sensors ensure real-time control and tracking of products sensitive to environmental parameters, such as vaccines, drugs or foodstuffs, during their manufacture as well as during storage and transport.
55.2% of the company's turnover is made in France.

Danone opens bond market with historical coupon at 1,125%

Pierre André Terisse, CFO of Danone Group, in the presence of the teams participating in the operation, celebrates the  €1,3 billion dual tranche bond issue of the 7th of January 2015.

Danone is a regular issuer on the bond market under EMTN programme since 1996. This year, Danone opened the market with a dual tranche operation, a 5-year floating rate note of  550 millions euros  (coupon of Euribor 3 months +à,33%) and a 10-year fixed rate bond of 750 millions euros  (coupon of 1,125%) and thus, reinforces the financial structure of the group. This operation was widely subscribed and enables to finance the development of the group at very attractive conditions.

Danone opens bond market with historical coupon at 1,125%

Pierre André Terisse, CFO of Danone Group, in the presence of the teams participating in the operation, celebrates the  €1,3 billion dual tranche bond issue of the 7th of January 2015.

Danone is a regular issuer on the bond market under EMTN programme since 1996. This year, Danone opened the market with a dual tranche operation, a 5-year floating rate note of  550 millions euros  (coupon of Euribor 3 months +à,33%) and a 10-year fixed rate bond of 750 millions euros  (coupon of 1,125%) and thus, reinforces the financial structure of the group. This operation was widely subscribed and enables to finance the development of the group at very attractive conditions.